Skip to main content

Table 1 Clinical information on the discovery and validation plasma sample cohorts

From: Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression

Discovery Cohort
  n (M/F) Age
Normal 8 (4/4) 67 ± 11
Polyps 8 (4/4) 65 ± 7
Adenoma 16 (8/8) 56 ± 6
Early Stage Cancer (Stage I/II) 8 (4/4) 65 ± 10
Advanced Cancer (Stage III/IV) 8 (4/4) 68 ± 8
Validation Cohort
  n (M/F) Age
Normal 20 (12/8) 63 ± 8
Polyps 20 (11/9) 57 ± 7
Adenoma 20 (12/8) 62 ± 10
Early Stage Cancer (Stage I/II) 23 (10/13) 63 ± 12
Advanced Cancer (Stage III/IV) 14 (9/5) 67 ± 8
  1. M denotes male; F denotes female.